These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30522735)

  • 1. Does Methylphenidate Normalize Brain Dysfunction During Fear Learning in Adolescents With Disruptive Behavior Disorders?
    Fairchild G
    J Am Acad Child Adolesc Psychiatry; 2018 Dec; 57(12):911-913. PubMed ID: 30522735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Methylphenidate During Fear Learning in Antisocial Adolescents: A Randomized Controlled fMRI Trial.
    van Lith K; Veltman DJ; Cohn MD; Pape LE; van den Akker-Nijdam ME; van Loon AWG; Bet P; van Wingen GA; van den Brink W; Doreleijers T; Popma A
    J Am Acad Child Adolesc Psychiatry; 2018 Dec; 57(12):934-943. PubMed ID: 30522739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Looming Threats and Animacy: Reduced Responsiveness in Youth with Disrupted Behavior Disorders.
    White SF; Thornton LC; Leshin J; Clanton R; Sinclair S; Coker-Appiah D; Meffert H; Hwang S; Blair JR
    J Abnorm Child Psychol; 2018 May; 46(4):741-754. PubMed ID: 28776147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 2: antipsychotics and traditional mood stabilizers.
    Pringsheim T; Hirsch L; Gardner D; Gorman DA
    Can J Psychiatry; 2015 Feb; 60(2):52-61. PubMed ID: 25886656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review and Meta-analysis of Neuroimaging in Oppositional Defiant Disorder (ODD) and Conduct Disorder (CD) Taking Attention-Deficit Hyperactivity Disorder (ADHD) Into Account.
    Noordermeer SD; Luman M; Oosterlaan J
    Neuropsychol Rev; 2016 Mar; 26(1):44-72. PubMed ID: 26846227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disrupted expected value signaling in youth with disruptive behavior disorders to environmental reinforcers.
    White SF; Fowler KA; Sinclair S; Schechter JC; Majestic CM; Pine DS; Blair RJ
    J Am Acad Child Adolesc Psychiatry; 2014 May; 53(5):579-88.e9. PubMed ID: 24745957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine.
    Pringsheim T; Hirsch L; Gardner D; Gorman DA
    Can J Psychiatry; 2015 Feb; 60(2):42-51. PubMed ID: 25886655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroanatomy of childhood disruptive behavior disorders.
    Fahim C; He Y; Yoon U; Chen J; Evans A; Pérusse D
    Aggress Behav; 2011; 37(4):326-37. PubMed ID: 21538379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The processing of animacy information is disrupted as a function of callous-unemotional traits in youth with disruptive behavior disorders.
    Thornton LC; Penner EA; Nolan ZT; Adalio CJ; Sinclair S; Meffert H; Hwang S; Blair RJR; White SF
    Neuroimage Clin; 2017; 16():498-506. PubMed ID: 28971003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telephone-assisted self-help for parents of children with attention-deficit/hyperactivity disorder who have residual functional impairment despite methylphenidate treatment: a randomized controlled trial.
    Dose C; Hautmann C; Buerger M; Schuermann S; Woitecki K; Doepfner M
    J Child Psychol Psychiatry; 2017 Jun; 58(6):682-690. PubMed ID: 27878809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fear extinction, persistent disruptive behavior and psychopathic traits: fMRI in late adolescence.
    Cohn MD; van Lith K; Kindt M; Pape LE; Doreleijers TA; van den Brink W; Veltman DJ; Popma A
    Soc Cogn Affect Neurosci; 2016 Jul; 11(7):1027-35. PubMed ID: 26048179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced activity within the dorsal endogenous orienting of attention network to fearful expressions in youth with disruptive behavior disorders and psychopathic traits.
    White SF; Williams WC; Brislin SJ; Sinclair S; Blair KS; Fowler KA; Pine DS; Pope K; Blair RJ
    Dev Psychopathol; 2012 Aug; 24(3):1105-16. PubMed ID: 22781874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality in individuals with disruptive behavior disorders diagnosed by specialist services - A nationwide cohort study.
    Scott JG; Giørtz Pedersen M; Erskine HE; Bikic A; Demontis D; McGrath JJ; Dalsgaard S
    Psychiatry Res; 2017 May; 251():255-260. PubMed ID: 28219025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. START NOW - a comprehensive skills training programme for female adolescents with oppositional defiant and conduct disorders: study protocol for a cluster-randomised controlled trial.
    Kersten L; Prätzlich M; Mannstadt S; Ackermann K; Kohls G; Oldenhof H; Saure D; Krieger K; Herpertz-Dahlmann B; Popma A; Freitag CM; Trestman RL; Stadler C
    Trials; 2016 Dec; 17(1):568. PubMed ID: 27903282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
    Dittmann RW; Schacht A; Helsberg K; Schneider-Fresenius C; Lehmann M; Lehmkuhl G; Wehmeier PM
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):97-110. PubMed ID: 21488751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of methylphenidate on oppositional defiant disorder comorbid with attention deficit/hyperactivity disorder.
    Serra-Pinheiro MA; Mattos P; Souza I; Pastura G; Gomes F
    Arq Neuropsiquiatr; 2004 Jun; 62(2B):399-402. PubMed ID: 15273834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbid disorders as moderators of response to family interventions among adolescents with bipolar disorder.
    Weintraub MJ; Axelson DA; Kowatch RA; Schneck CD; Miklowitz DJ
    J Affect Disord; 2019 Mar; 246():754-762. PubMed ID: 30623821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole/Methylphenidate Combination in Children and Adolescents with Disruptive Mood Dysregulation Disorder and Attention-Deficit/Hyperactivity Disorder: An Open-Label Study.
    Pan PY; Fu AT; Yeh CB
    J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):682-689. PubMed ID: 30148656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Methylphenidate on Emotional Dysregulation in Children With Attention-Deficit/Hyperactivity Disorder + Oppositional Defiant Disorder/Conduct Disorder.
    Kutlu A; Akyol Ardic U; Ercan ES
    J Clin Psychopharmacol; 2017 Apr; 37(2):220-225. PubMed ID: 28225747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Children with ADHD and symptoms of oppositional defiant disorder improved in behavior when treated with methylphenidate and adjuvant risperidone, though weight gain was also observed - Results from a randomized, double-blind, placebo-controlled clinical trial.
    Jahangard L; Akbarian S; Haghighi M; Ahmadpanah M; Keshavarzi A; Bajoghli H; Sadeghi Bahmani D; Holsboer-Trachsler E; Brand S
    Psychiatry Res; 2017 May; 251():182-191. PubMed ID: 28213188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.